Assignee
WYETH LLC
US·257 granted patents·112 pending applications·1,808 citations·filing 2001–2025
Top patents by PatentIndex Score
369 records- 0198US10716848B2Process for preparing pneumococcal polysaccharide-protein conjugatesWYETH LLC·Filed 2020·Granted Jul 21, 2020·9 cites·13 claims
- 0298US7951907B2Circovirus sequences associated with piglet weight loss disease (PWD)WYETH LLC·Filed 2009·Granted May 31, 2011·42 cites·7 claims
- 0397US10406220B2Pneumococcal dosing regimenWYETH LLC·Filed 2017·Granted Sep 10, 2019·24 cites·9 claims
- 0497US9669084B2Pneumococcal dosing regimenWYETH LLC·Filed 2014·Granted Jun 6, 2017·33 cites·16 claims
- 0597US9187536B1Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Nov 17, 2015·19 cites·20 claims
- 0697US7888486B2Antagonist antibodies against GDF-8WYETH LLC·Filed 2006·Granted Feb 15, 2011·86 cites·22 claims
- 0796US10774117B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2017·Granted Sep 15, 2020·6 cites·31 claims
- 0896USRE44768ERapamycin hydroxyestersWYETH LLC·Filed 2013·Granted Feb 18, 2014·46 cites·26 claims
- 0996US8557548B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Oct 15, 2013·25 cites·21 claims
- 1096US7959927B2Mycoplasma hyopneumoniae bacterin vaccineWYETH LLC·Filed 2009·Granted Jun 14, 2011·27 cites·16 claims
- 1196US7955605B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2006·Granted Jun 7, 2011·47 cites·15 claims
- 1296US7709001B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2006·Granted May 4, 2010·60 cites·16 claims
- 1395US12303592B2Formulations for parenteral delivery of compounds and uses thereofWYETH LLC·Filed 2023·Granted May 20, 2025·1 cites·19 claims
- 1495US11077180B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2019·Granted Aug 3, 2021·8 cites·2 claims
- 1595US9981035B2Process for preparing pneumococcal polysaccharide-protein conjugatesWYETH LLC·Filed 2016·Granted May 29, 2018·15 cites·4 claims
- 1695US9745354B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2014·Granted Aug 29, 2017·15 cites·28 claims
- 1795USRE46518ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2016·Granted Aug 22, 2017·9 cites·48 claims
- 1895US9399060B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2014·Granted Jul 26, 2016·21 cites·13 claims
- 1995US8900597B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Dec 2, 2014·15 cites·41 claims
- 2095US8044178B2Anti-5T4 antibodies and uses thereofWYETH LLC·Filed 2007·Granted Oct 25, 2011·41 cites·31 claims
- 2195US7645752B2Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptorsWYETH LLC·Filed 2007·Granted Jan 12, 2010·59 cites·29 claims
- 2294USRE48862ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2394US10597428B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Mar 24, 2020·7 cites·20 claims
- 2494USRE46376ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Apr 25, 2017·9 cites·21 claims
- 2594US7982043B2Protein tyrosine kinase enzyme inhibitorsWYETH LLC·Filed 2008·Granted Jul 19, 2011·13 cites·1 claims
- 2694US7884109B2Purine and imidazopyridine derivatives for immunosuppressionWYETH LLC·Filed 2007·Granted Feb 8, 2011·58 cites·5 claims
- 2794US7714111B2Arginine derivative wash in protein purification using affinity chromatographyWYETH LLC·Filed 2007·Granted May 11, 2010·25 cites·47 claims
- 2893USRE48863ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2993US10512681B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2017·Granted Dec 24, 2019·12 cites·20 claims
- 3093US9981045B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2015·Granted May 29, 2018·13 cites·8 claims
- 3193US8956608B2Method for treating sarcopenia using antagonist antibodies against GDF-8WYETH LLC·Filed 2013·Granted Feb 17, 2015·16 cites·19 claims
- 3293US7879828B2Tigecycline compositions and methods of preparationWYETH LLC·Filed 2006·Granted Feb 1, 2011·16 cites·23 claims
- 3393US7758860B2Protein formulations with reduced viscosity and uses thereofWYETH LLC·Filed 2008·Granted Jul 20, 2010·44 cites·19 claims
- 3492US9480736B2Multivalent pneumococcal polysaccharide-protein conjugate compositionWYETH LLC·Filed 2014·Granted Nov 1, 2016·13 cites·4 claims
- 3592US8383857B2Processes for making hydrazidesWYETH LLC·Filed 2012·Granted Feb 26, 2013·6 cites·19 claims
- 3692US8372625B2Polynucleotides encoding antagonist antibodies against GDF-8WYETH LLC·Filed 2011·Granted Feb 12, 2013·16 cites·23 claims
- 3792US8350013B2Arginine wash in protein purification using affinity chromatographyWYETH LLC·Filed 2007·Granted Jan 8, 2013·19 cites·16 claims
- 3892US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 3992US7910107B2Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disordersWYETH LLC·Filed 2009·Granted Mar 22, 2011·29 cites·14 claims
- 4091US11535652B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 27, 2022·2 cites·19 claims
- 4191US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 4291US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 4391US8562999B2Formulations which stabilize and inhibit precipitation of immunogenic compositionsWYETH LLC·Filed 2012·Granted Oct 22, 2013·21 cites·22 claims
- 4491US8496934B2Method for treating cachexia using antagonist antibodies against GDF-8WYETH LLC·Filed 2012·Granted Jul 30, 2013·13 cites·19 claims
- 4591US8022216B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2008·Granted Sep 20, 2011·14 cites·4 claims
- 4691US7901684B2Antibodies against human IL-22 and uses thereforWYETH LLC·Filed 2007·Granted Mar 8, 2011·14 cites·10 claims
- 4791US7750122B2Anti-TrkB monoclonal antibodies and uses thereofWYETH LLC·Filed 2006·Granted Jul 6, 2010·28 cites·27 claims
- 4891US7666439B2Mycoplasma hyopneumoniae bacterin vaccineWYETH LLC·Filed 2006·Granted Feb 23, 2010·7 cites·5 claims
- 4990US7935787B2Formulations which stabilize and inhibit precipitation of immunogenic compositionsWYETH LLC·Filed 2007·Granted May 3, 2011·19 cites·26 claims
- 5090US7754689B2Finger-1 peptide analogs of the TGF-β superfamilyWYETH LLC·Filed 2007·Granted Jul 13, 2010·16 cites·8 claims
Showing the top 50 of 369 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when WYETH LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →